BACKGROUND: Steroid-induced osteonecrosis of the femoral head (ONFH) in young adults is a challenging disorder that can impairs the quality of life of a patient. The disease also leads to frequent occurrences of collapse of the femoral head and resultant dysfunction of the hip joint. In recent years, some scholars have studied steroid-induced lipid metabolism disorder and achieved the effect of steroid-induced ONFH treatment. This study aims to
review the investigations on the hepatic
CYP3A (cytochrome P4503A enzyme) genetic polymorphisms in steroid-induced ONFH patients. We then further explore its activity correlation with the development of steroid-induced ONFH in a rabbit model.
METHODS: A systematic literature search of articles was conducted in PubMed, Web of Science, Google Scholar, Springerlink, and the Chinese National Knowledge Infrastructure database up to February 2017. Twelve relevant articles were retrieved. The odds ratios, standard mean difference, and 95% confidence intervals were calculated to assess the effect of hepatic
CYP3A activity on the rabbit model with steroid-induced ONFH. Fixed-effects and random-effects models were used to analyze the heterogeneity. Begg\'s funnel plot was used to assess publication bias.
RESULTS: High hepatic
CYP3A activity significantly decreased the risk for steroid-induced ONFH in the rabbit model (p <. 05). The
CYP3A gene may be potentially associated with increased risk of steroid-induced ONFH in the human allele model.
CONCLUSIONS: The study suggests that high hepatic
CYP3A activity decreases the risk of steroid-induced ONFH.